The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Mifepristone results in increased expression of ABCB11 mRNA Mifepristone results in decreased activity of ABCB11 protein Mifepristone inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Mifepristone results in increased expression of ABCB1A mRNA ABCB1 protein affects the reaction [Mifepristone results in decreased transport of calcein AM]
[Mifepristone results in increased activity of NR1I2 protein] which results in increased expression of ABCC3 mRNA Mifepristone results in increased expression of ABCC3 mRNA Mifepristone results in increased activity of ABCC3 protein
Mifepristone inhibits the reaction [Corticosterone results in increased expression of ACE mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ACE mRNA]
Mifepristone inhibits the reaction [Progesterone results in increased expression of ADAMTS1 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of ADAMTS1 protein] Mifepristone results in decreased expression of ADAMTS1 mRNA
Mifepristone inhibits the reaction [butylparaben results in increased expression of ADIPOQ mRNA] Mifepristone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]
Mifepristone inhibits the reaction [Corticosterone results in increased expression of AGTR2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of AGTR2 mRNA]
Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of AHR mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of AHR protein] Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin binds to AHR protein]]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of AHR mRNA] Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA]] Mifepristone results in increased activity of AHR protein
Mifepristone inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]; Mifepristone inhibits the reaction [Progesterone results in increased phosphorylation of AKT1 protein]; Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of AKT1 protein]
Mifepristone results in increased expression of ANXA1 mRNA Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [EGFR protein binds to ANXA1 protein modified form]]; Mifepristone inhibits the reaction [Dexamethasone results in increased localization of ANXA1 protein modified form]; Mifepristone inhibits the reaction [Dexamethasone results in increased phosphorylation of and results in increased expression of ANXA1 protein]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of ANXA1 mRNA]
[Mifepristone binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 enhancer]; [Mifepristone binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 promoter]; [Mifepristone binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 enhancer]; [Mifepristone binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 promoter]; [Mifepristone binds to AR protein] promotes the reaction [NCOR1 protein binds to KLK3 promoter]; Mifepristone binds to and results in decreased activity of AR protein; Mifepristone binds to and results in decreased activity of AR protein mutant form; Mifepristone inhibits the reaction [Fludrocortisone results in increased activity of AR protein mutant form]; Mifepristone inhibits the reaction [Flutamide results in increased activity of AR protein mutant form]; Mifepristone inhibits the reaction [Metribolone binds to and results in increased activity of AR protein]; Mifepristone inhibits the reaction [Metribolone results in increased activity of AR protein mutant form]; Mifepristone inhibits the reaction [Metribolone results in increased activity of AR protein] [Mifepristone binds to AR protein] which binds to KLK3 enhancer; [Mifepristone binds to AR protein] which binds to KLK3 promoter; Mifepristone binds to AR protein Mifepristone results in decreased activity of AR protein
Mifepristone inhibits the reaction [Dexamethasone results in decreased phosphorylation of BAD protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BAD mRNA] Mifepristone inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Rotenone results in increased phosphorylation of BAD protein]]
Mifepristone affects the localization of BAX protein Mifepristone results in increased expression of BAX mRNA; Mifepristone results in increased expression of BAX protein
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2] Mifepristone results in decreased expression of BCL2 mRNA; Mifepristone results in decreased expression of BCL2 protein Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]
Mifepristone affects the reaction [Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form]]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of BCL2L1 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2L1 protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of BCL2L1 protein]; Mifepristone promotes the reaction [Tretinoin results in increased expression of BCL2L1 mRNA]
Mifepristone results in decreased expression of BDNF protein Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF protein]]; Mifepristone inhibits the reaction [Dexamethasone results in decreased acetylation of BDNF exon]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BDNF mRNA]
Mifepristone inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA]]; Mifepristone inhibits the reaction [Triclosan results in increased expression of C3 mRNA]; Mifepristone promotes the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA]
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of CALM2 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of CALM2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of CALM2 mRNA]
[Etoposide co-treated with Mifepristone] results in increased activity of CASP3 protein; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP3 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP3 protein]] Mifepristone results in decreased expression of CASP3 protein Mifepristone inhibits the reaction [Dexamethasone results in increased activity of CASP3 protein] Mifepristone results in increased activity of CASP3 protein Mifepristone inhibits the reaction [Corticosterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in increased cleavage of CASP3 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in increased expression of CASP3 mRNA]]; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein]]
[Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased activity of CAT protein] [Mifepristone co-treated with Paraquat] results in decreased activity of CAT protein; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in decreased activity of CAT protein]
[Mifepristone binds to and results in decreased activity of PGR protein] which results in increased expression of CCL2 mRNA; [Mifepristone binds to and results in decreased activity of PGR protein] which results in increased expression of CCL2 protein Mifepristone results in decreased expression of CCL2 mRNA
Mifepristone inhibits the reaction [CDK2 protein binds to CCNE1 protein]; Mifepristone results in decreased expression of and results in decreased localization of CCNE1 protein
Mifepristone inhibits the reaction [[Dexamethasone co-treated with CD28 protein] results in increased expression of NFKBIA mRNA]; Mifepristone inhibits the reaction [[rimexolone co-treated with CD28 protein] results in increased expression of NFKBIA mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of IFNG protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of IL2 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of TNF protein]]; Mifepristone inhibits the reaction [rimexolone inhibits the reaction [CD28 protein results in increased secretion of IFNG protein]]; Mifepristone inhibits the reaction [rimexolone inhibits the reaction [CD28 protein results in increased secretion of IL2 protein]]; Mifepristone inhibits the reaction [rimexolone inhibits the reaction [CD28 protein results in increased secretion of TNF protein]]
Mifepristone results in decreased expression of CD36 mRNA Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CD36 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CD36 protein]
Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CD4 protein]; Mifepristone inhibits the reaction [rimexolone results in decreased expression of CD4 protein] Mifepristone results in decreased expression of CD4 protein
Mifepristone inhibits the reaction [[diethyl phthalate co-treated with Lipopolysaccharides] results in decreased expression of CD86 protein]; Mifepristone inhibits the reaction [[perfluorooctane sulfonic acid co-treated with Lipopolysaccharides] results in decreased expression of CD86 protein]
Mifepristone results in increased expression of CDK1 mRNA Mifepristone results in decreased expression of CDK1 protein Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDK1 protein]
Mifepristone inhibits the reaction [CDK2 protein binds to CCNE1 protein]; Mifepristone promotes the reaction [CDK2 protein binds to CDKN1B protein]; Mifepristone promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]; Mifepristone promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]; Mifepristone results in decreased localization of and results in decreased expression of CDK2 protein
Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1A protein]; Mifepristone promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]; Mifepristone results in increased expression of and results in increased localization of CDKN1A protein
Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B protein]; Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein]; Mifepristone promotes the reaction [CDK2 protein binds to CDKN1B protein]; Mifepristone promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]; Mifepristone results in increased expression of and results in increased localization of CDKN1B protein Mifepristone results in increased expression of CDKN1B mRNA; Mifepristone results in increased expression of CDKN1B protein
Mifepristone inhibits the reaction [bisphenol A results in increased expression of CEBPA mRNA]; Mifepristone inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of CEBPA mRNA]
Mifepristone promotes the reaction [CEBPB protein binds to NR3C1 protein] Mifepristone affects the reaction [Hydrocortisone affects the expression of CEBPB mRNA]
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]] Mifepristone results in decreased expression of CFLAR mRNA
Mifepristone results in decreased expression of COL2A1 mRNA Mifepristone inhibits the reaction [Corticosterone results in decreased expression of COL2A1 mRNA]
[Mifepristone binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 enhancer]; [Mifepristone binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 promoter]
Mifepristone inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]]
Mifepristone results in decreased expression of CXCL1 mRNA Mifepristone inhibits the reaction [Halothane results in increased expression of CXCL1 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; Mifepristone inhibits the reaction [Progesterone results in increased expression of CXCL1 mRNA]
[Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A1 protein Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]]
[Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A2 protein; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]]
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]]
Mifepristone results in increased expression of CYP3A4 mRNA [Mifepristone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Mifepristone inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]; Mifepristone inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; Mifepristone inhibits the reaction [CYP3A4 protein results in increased metabolism of Midazolam]; Mifepristone inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]; Mifepristone inhibits the reaction [NR3C1 protein promotes the reaction [Dexamethasone results in increased expression of CYP3A4 mRNA]]; NR1I2 protein promotes the reaction [Mifepristone results in increased expression of CYP3A4 mRNA] Mifepristone results in decreased activity of CYP3A4 protein
Mifepristone inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Mifepristone inhibits the reaction [Budesonide results in increased expression of CYP3A5 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CYP3A5 mRNA]
Mifepristone results in decreased expression of DDIT4 mRNA Mifepristone inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]
Mifepristone results in increased expression of DIO2 mRNA Mifepristone inhibits the reaction [Glucocorticoids promotes the reaction [Lipopolysaccharides results in increased activity of DIO2 protein]]; Mifepristone inhibits the reaction [Glucocorticoids promotes the reaction [Lipopolysaccharides results in increased expression of DIO2 mRNA]]; Mifepristone inhibits the reaction [Glucocorticoids results in increased activity of DIO2 protein]; Mifepristone inhibits the reaction [Glucocorticoids results in increased expression of DIO2 mRNA]
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of DKK1 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of DKK1 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of DKK1 protein] Mifepristone inhibits the reaction [Corticosterone results in increased expression of DKK1 protein]
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to ARAF protein]]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to GRB2 protein]]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K1 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein results in increased phosphorylation of MAPK8 protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]] Mifepristone results in decreased expression of EGF mRNA
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to ARAF protein]]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to GRB2 protein]]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [EGFR protein binds to ANXA1 protein modified form]] Mifepristone results in decreased expression of EGFR mRNA
Mifepristone inhibits the reaction [Progesterone inhibits the reaction [bisphenol A results in increased expression of EGR1 mRNA]]; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA]]
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of F2R mRNA]; Mifepristone inhibits the reaction [etonogestrel results in increased expression of F2R mRNA]; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of F2R mRNA]
Mifepristone inhibits the reaction [Progesterone results in increased expression of F3 protein] Mifepristone results in decreased expression of F3 mRNA
Mifepristone results in increased expression of FABP4 protein [Mifepristone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Mifepristone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of FABP4 protein] Mifepristone inhibits the reaction [bisphenol A results in increased expression of FABP4 mRNA]
Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP3 protein]]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein]]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]]; Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]]
Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]] Mifepristone results in increased expression of FASLG mRNA
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of FASN mRNA]; Mifepristone inhibits the reaction [Norethynodrel results in increased activity of FASN protein]
Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA] Mifepristone results in decreased expression of FBLN1 mRNA
Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of FOXL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of FOXL2 protein] Mifepristone results in increased expression of FOXL2 mRNA; Mifepristone results in increased expression of FOXL2 protein
[Mifepristone co-treated with Dexamethasone] results in decreased expression of G6PC1 mRNA; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of G6PC1 protein]
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of GATA4 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of GATA4 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of GATA4 mRNA]
Acetaminophen promotes the reaction [Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]]; Mifepristone results in increased activity of [GCLC protein binds to GCLM protein] Mifepristone results in increased expression of GCLC protein
Mifepristone results in increased expression of GCLM protein Acetaminophen promotes the reaction [Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]]; Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]
Mifepristone results in increased expression of GSTA2 mRNA Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTA2 mRNA]]
Mifepristone results in increased expression of HDAC2 mRNA Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of HDAC2 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of HDAC2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of HDAC2 protein]
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of HDAC7 mRNA] Mifepristone inhibits the reaction [Corticosterone results in increased expression of HDAC7 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of HDAC7 protein]
Mifepristone results in decreased expression of HMOX1 mRNA [Mifepristone co-treated with Paraquat] results in increased expression of HMOX1 mRNA; NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of HMOX1 mRNA]
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of and results in increased activity of HPGD protein] Mifepristone results in decreased expression of HPGD mRNA
[Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]; Mifepristone affects the reaction [Hydrocortisone affects the expression of HSD11B1 mRNA]; Mifepristone inhibits the reaction [bisphenol A results in increased expression of HSD11B1 mRNA] [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [HSD11B1 protein results in decreased activity of NFE2L2 protein] Mifepristone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]]
Masoprocol promotes the reaction [Mifepristone results in increased activity of HSD11B2 protein]; Mifepristone inhibits the reaction [12-Hydroxy-5,8,10,14-eicosatetraenoic Acid results in decreased activity of HSD11B2 protein]; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of HSD11B2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased activity of HSD11B2 protein]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of HSD11B2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of HSD11B2 protein] Mifepristone results in increased expression of HSD11B2 mRNA; Mifepristone results in increased expression of HSD11B2 protein
Mifepristone inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]]; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]] Mifepristone inhibits the reaction [Halothane results in increased expression of ICAM1 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of ICAM1 mRNA]] Mifepristone results in decreased expression of ICAM1 mRNA
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of IFNG protein]]; Mifepristone inhibits the reaction [Dydrogesterone results in decreased expression of IFNG protein]; Mifepristone inhibits the reaction [rimexolone inhibits the reaction [CD28 protein results in increased secretion of IFNG protein]] Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of IFNG protein]
Mifepristone inhibits the reaction [[Estradiol co-treated with Progesterone] results in increased secretion of IGF1 protein]; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of IGF1 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased secretion of IGF1 protein] Mifepristone results in decreased expression of IGF1 mRNA
[Nadolol co-treated with Mifepristone] promotes the reaction [methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]] [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased expression of IL10 protein]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL10 mRNA]
[Nadolol co-treated with Mifepristone] inhibits the reaction [methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL12B protein]] Mifepristone inhibits the reaction [R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of IL12B protein]]
[fulvestrant co-treated with Mifepristone] inhibits the reaction [[Progesterone co-treated with Estrogens] inhibits the reaction [Lipopolysaccharides results in increased expression of IL18 mRNA]]
[Mifepristone co-treated with Paraquat] results in increased expression of IL1B protein; Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PLAT mRNA]]; Mifepristone promotes the reaction [IL1B protein results in increased expression of SERPINE1 protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL1B protein] Mifepristone inhibits the reaction [Ethanol results in decreased expression of IL1B mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL1B mRNA]] Mifepristone inhibits the reaction [Fluticasone inhibits the reaction [IL1B protein results in increased expression of SELE mRNA]]
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of IL2 protein]]; Mifepristone inhibits the reaction [rimexolone inhibits the reaction [CD28 protein results in increased secretion of IL2 protein]] Mifepristone inhibits the reaction [Ethanol results in decreased expression of IL2 mRNA]
Mifepristone inhibits the reaction [Dydrogesterone results in increased expression of IL4 protein] Mifepristone inhibits the reaction [Ethanol results in decreased expression of IL4 mRNA]
[Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of IL6 mRNA]; Mifepristone inhibits the reaction [Dydrogesterone results in increased expression of IL6 protein] Mifepristone results in decreased secretion of IL6 protein Mifepristone inhibits the reaction [ciglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL6 mRNA]]; Mifepristone inhibits the reaction [rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]] [Mifepristone co-treated with Paraquat] results in increased expression of IL6 protein; Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL6 protein]
[Mifepristone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Mifepristone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Mifepristone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]
Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein]
[Mifepristone binds to AR protein] which binds to KLK3 enhancer; [Mifepristone binds to AR protein] which binds to KLK3 promoter [Mifepristone binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 enhancer]; [Mifepristone binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 promoter]; [Mifepristone binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 enhancer]; [Mifepristone binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 promoter]; [Mifepristone binds to AR protein] promotes the reaction [NCOR1 protein binds to KLK3 promoter]
Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of LDLR mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of LDLR protein]; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of LDLR mRNA]
Mifepristone promotes the reaction [[Tetrachlorodibenzodioxin co-treated with Gonadotropins, Equine] results in increased expression of LHB protein] Mifepristone results in increased secretion of LHB protein
Mifepristone inhibits the reaction [Progesterone results in increased expression of LPAR3 mRNA] Mifepristone results in decreased expression of LPAR3 mRNA
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of LY6E mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of LY6E mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of LY6E mRNA]
Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of MAPK1 protein modified form]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK1 protein]] Mifepristone results in increased phosphorylation of and results in increased activity of MAPK1 protein Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein]
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of MAPK3 protein modified form]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased phosphorylation of MAPK3 protein]] Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of MAPK3 protein] Mifepristone results in increased phosphorylation of and results in increased activity of MAPK3 protein
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MIR17 mRNA] Mifepristone results in decreased expression of MIR17 mRNA
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP2 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP2 protein]]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of MMP2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of MMP2 protein] Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP2 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP2 protein]]
Mifepristone results in increased expression of MMP3 mRNA Mifepristone inhibits the reaction [Progesterone results in decreased expression of MMP3 mRNA]
Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]] Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 protein]]; Mifepristone inhibits the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]]
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MSTN mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MSTN protein]
Mifepristone inhibits the reaction [[Dexamethasone co-treated with Doxorubicin] results in increased expression of MYH7 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Verapamil results in decreased expression of MYH7 mRNA]]
Mifepristone inhibits the reaction [[Dexamethasone co-treated with Doxorubicin] results in increased expression of MYL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [[Verapamil co-treated with Doxorubicin] results in decreased expression of MYL2 mRNA]]
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of MYLK3 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of MYLK3 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of MYLK3 mRNA]
[Mifepristone binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 enhancer]; [Mifepristone binds to AR protein] promotes the reaction [NCOA2 protein binds to KLK3 promoter]
[Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [HSD11B1 protein results in decreased activity of NFE2L2 protein]; [Mifepristone co-treated with Paraquat] results in increased expression of NFE2L2 mRNA; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in decreased activity of CAT protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL1B protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL6 protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of RELA protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of TNF protein]; NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of HMOX1 mRNA]; NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of NQO1 mRNA] [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased activity of CAT protein]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased expression of IL10 protein]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP3 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP9 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CYCS mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL10 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 protein]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF protein]
Mifepristone inhibits the reaction [Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]]
Mifepristone inhibits the reaction [[Dexamethasone co-treated with CD28 protein] results in increased expression of NFKBIA mRNA]; Mifepristone inhibits the reaction [[rimexolone co-treated with CD28 protein] results in increased expression of NFKBIA mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of NFKBIA mRNA]
Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS2 protein] Mifepristone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
Mifepristone inhibits the reaction [ginsenoside Re results in increased phosphorylation of NOS3 protein]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]]; Mifepristone inhibits the reaction [Progesterone results in increased expression of and results in increased phosphorylation of NOS3 protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS3 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS3 protein] Mifepristone results in decreased expression of NOS3 protein
Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of NPHS1 mRNA]
Mifepristone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NPPA mRNA] Mifepristone inhibits the reaction [[Dexamethasone co-treated with Doxorubicin] results in increased expression of NPPA mRNA]
Mifepristone results in decreased expression of NQO1 mRNA [Mifepristone co-treated with Paraquat] results in increased expression of NQO1 mRNA; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [benz(a)anthracene results in increased activity of NQO1 protein]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]]; NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of NQO1 mRNA]
[Mifepristone results in increased activity of NR1I2 protein] which results in increased expression of ABCC3 mRNA; [Mifepristone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Mifepristone binds to and results in increased activity of NR1I2 protein; NR1I2 protein promotes the reaction [Mifepristone results in increased expression of CYP3A4 mRNA] Mifepristone inhibits the reaction [Dexamethasone results in increased expression of NR1I2 mRNA] Mifepristone results in increased expression of NR1I2 mRNA
[Mifepristone results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of NR1I3 mRNA] Mifepristone results in increased expression of NR1I3 mRNA
[Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] which results in decreased susceptibility to Dexamethasone; Mifepristone analog binds to and results in decreased activity of NR3C1 protein; Mifepristone binds to and results in decreased activity of NR3C1 protein; Mifepristone inhibits the reaction [Dexamethasone affects the localization of NR3C1 protein]; Mifepristone inhibits the reaction [Dexamethasone binds to and results in increased activity of NR3C1 protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of NR3C1 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased activity of NR3C1 protein]; Mifepristone inhibits the reaction [Hydrocortisone affects the localization of NR3C1 protein]; Mifepristone inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; Mifepristone inhibits the reaction [NR3C1 protein promotes the reaction [Dexamethasone results in increased expression of CYP3A4 mRNA]]; Mifepristone inhibits the reaction [teriflunomide results in increased activity of NR3C1 protein] Mifepristone binds to NR3C1 protein Mifepristone binds to and results in decreased activity of NR3C1 protein; Mifepristone binds to and results in increased activity of NR3C1 protein; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein] [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [HSD11B1 protein results in decreased activity of NFE2L2 protein]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] which results in decreased susceptibility to Morphine; Mifepristone binds to and results in decreased activity of NR3C1 protein; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]]; Mifepristone inhibits the reaction [Dexamethasone affects the localization of NR3C1 protein]; Mifepristone promotes the reaction [CEBPB protein binds to NR3C1 protein] Mifepristone results in decreased expression of NR3C1 mRNA; Mifepristone results in decreased expression of NR3C1 protein NR3C1 protein binds to Mifepristone Mifepristone results in increased activity of NR3C1 protein Mifepristone results in increased expression of NR3C1 mRNA Mifepristone results in decreased activity of NR3C1 protein
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of NTRK2 protein]]
Mifepristone inhibits the reaction [Dexamethasone results in increased cleavage of PARP1 protein] Mifepristone results in increased cleavage of PARP1 protein
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Clofibrate results in increased expression of PCK1 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [rosiglitazone results in increased expression of PCK1 mRNA]] Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA] [Mifepristone co-treated with Dexamethasone] results in decreased expression of PCK1 mRNA; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of PCK1 protein]
Mifepristone analog binds to and results in decreased activity of PGR protein; Mifepristone binds to and results in decreased activity of PGR protein; Mifepristone inhibits the reaction [16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased activity of PGR protein]; Mifepristone inhibits the reaction [[Progestins results in increased activity of PGR protein] which results in increased expression of VEGFA]; Mifepristone inhibits the reaction [methoxyacetic acid promotes the reaction [Promegestone results in increased activity of PGR protein]]; Mifepristone inhibits the reaction [Progesterone results in increased expression of PGR protein]; Mifepristone promotes the reaction [Progesterone affects the expression of PGR mRNA] Mifepristone affects the activity of PGR protein Mifepristone binds to and results in decreased activity of PGR protein; Mifepristone inhibits the reaction [bisphenol A results in increased expression of PGR protein]; Mifepristone inhibits the reaction [octylphenol results in increased expression of PGR protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of PGR mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of PGR protein] Mifepristone results in decreased activity of PGR protein [Mifepristone binds to and results in decreased activity of PGR protein] which results in decreased susceptibility to Progesterone; [Mifepristone binds to and results in decreased activity of PGR protein] which results in increased expression of CCL2 mRNA; [Mifepristone binds to and results in decreased activity of PGR protein] which results in increased expression of CCL2 protein; Mifepristone binds to and results in decreased activity of PGR protein; Mifepristone inhibits the reaction [Progesterone results in increased expression of PGR mRNA] Mifepristone results in decreased expression of PGR protein
Mifepristone results in increased expression of PLAT mRNA Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PLAT mRNA]] Mifepristone results in decreased expression of PLAT mRNA
Mifepristone inhibits the reaction [Progesterone inhibits the reaction [bisphenol A results in increased phosphorylation of PLN protein]]; Mifepristone inhibits the reaction [progesterone-11-bovine serum albumin inhibits the reaction [bisphenol A results in increased phosphorylation of PLN protein]]
Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] Mifepristone results in decreased expression of PPARG mRNA Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]
Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of PRL mRNA] Mifepristone results in increased expression of PRL mRNA Mifepristone promotes the reaction [estradiol 3-benzoate results in increased secretion of PRL protein] Mifepristone results in increased expression of PRL mRNA; Mifepristone results in increased expression of PRL protein
[Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of PTGS2 protein]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of PTGS2 protein]
Mifepristone results in increased expression of RAP1B mRNA Mifepristone inhibits the reaction [Progesterone results in increased expression of RAP1B mRNA]
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of RBP4 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of RBP4 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of RBP4 mRNA]
Mifepristone inhibits the reaction [Dexamethasone results in decreased phosphorylation of and affects the localization of RELA protein]; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]] [Mifepristone co-treated with Paraquat] results in increased expression of RELA protein; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of RELA protein]
7-hydroxystaurosporine promotes the reaction [Mifepristone inhibits the reaction [Progesterone results in increased expression of RRM2 protein]]; Mifepristone inhibits the reaction [Progesterone results in increased expression of RRM2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of RRM2 protein]
Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-G mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-G protein]
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of RYR2 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of RYR2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of RYR2 mRNA]
Mifepristone inhibits the reaction [bisphenol A results in increased expression of S100G mRNA]; Mifepristone inhibits the reaction [bisphenol A results in increased expression of S100G protein]; Mifepristone inhibits the reaction [Estradiol results in increased expression of S100G mRNA]; Mifepristone inhibits the reaction [nonylphenol results in increased expression of S100G mRNA]; Mifepristone inhibits the reaction [nonylphenol results in increased expression of S100G protein]; Mifepristone inhibits the reaction [octylphenol results in increased expression of S100G mRNA]; Mifepristone inhibits the reaction [octylphenol results in increased expression of S100G protein]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of S100G mRNA] Mifepristone inhibits the reaction [Triclosan results in increased expression of S100G mRNA]; Mifepristone inhibits the reaction [Triclosan results in increased expression of S100G protein]
Mifepristone inhibits the reaction [Calcitriol results in increased expression of SEMA3B protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of SEMA3B protein] SEMA3B protein results in increased susceptibility to Mifepristone
Mifepristone inhibits the reaction [Calcitriol results in increased expression of SEMA3F protein]; Mifepristone inhibits the reaction [Progesterone results in increased expression of SEMA3F protein] SEMA3F protein results in increased susceptibility to Mifepristone
Mifepristone results in decreased expression of SERPINE1 mRNA Mifepristone promotes the reaction [IL1B protein results in increased expression of SERPINE1 protein]
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of SLC12A5 protein]]
Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Fructose results in increased activity of SLC2A5 protein]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Fructose results in increased expression of SLC2A5 mRNA]]
Dexamethasone inhibits the reaction [Mifepristone results in increased expression of SOD2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of SOD2 mRNA] [Mifepristone co-treated with TNF protein] results in increased expression of SOD2 mRNA; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]]
Mifepristone results in decreased expression of STAR mRNA Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of STAR mRNA] Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of STAR mRNA]
Mifepristone inhibits the reaction [Progesterone results in increased expression of SULT1E1 mRNA]; Mifepristone inhibits the reaction [Progesterone results in increased expression of SULT1E1 protein]
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of TAT mRNA] Mifepristone inhibits the reaction [Dexamethasone results in increased activity of TAT protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of TAT mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of TAT mRNA]
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of TBX20 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of TBX20 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of TBX20 mRNA]
[Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF protein]; [Mifepristone co-treated with TNF protein] results in increased expression of SOD2 mRNA; Mifepristone inhibits the reaction [[diethyl phthalate co-treated with Lipopolysaccharides] results in decreased expression of TNF protein]; Mifepristone inhibits the reaction [[perfluorooctane sulfonic acid co-treated with Lipopolysaccharides] results in decreased expression of TNF protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of TNF protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]]; Mifepristone inhibits the reaction [Dydrogesterone results in decreased expression of TNF protein]; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]]; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased expression of CXCL8 mRNA]]; Mifepristone inhibits the reaction [rimexolone inhibits the reaction [CD28 protein results in increased secretion of TNF protein]] Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of TNF protein]; Mifepristone inhibits the reaction [Halothane results in increased expression of TNF mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of TNF mRNA]] TNF protein affects the susceptibility to Mifepristone [Mifepristone co-treated with Paraquat] results in increased expression of TNF protein; Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of TNF protein]; NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of TNF protein]
Mifepristone inhibits the reaction [CORT protein results in increased expression of TNFRSF11B mRNA]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of TNFRSF11B mRNA]
Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]]
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of TNNI3 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of TNNI3 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of TNNI3 mRNA]
Mifepristone inhibits the reaction [bisphenol A results in decreased expression of TRPV2 mRNA]; Mifepristone inhibits the reaction [bisphenol A results in decreased expression of TRPV2 protein]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of TRPV2 mRNA]; Mifepristone inhibits the reaction [octylphenol results in decreased expression of TRPV2 protein]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of TRPV2 mRNA]; Mifepristone inhibits the reaction [Progesterone results in decreased expression of TRPV2 protein]
[Mifepristone co-treated with Dexamethasone] results in decreased expression of TSC22D3 mRNA; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]
Mifepristone inhibits the reaction [Medroxyprogesterone Acetate inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]]; Mifepristone inhibits the reaction [Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]] Mifepristone results in decreased expression of VCAM1 mRNA
Mifepristone inhibits the reaction [[Progestins results in increased activity of PGR protein] which results in increased expression of VEGFA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of VEGFA mRNA]; Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of VEGFA mRNA]; Mifepristone inhibits the reaction [Progestins results in increased expression of VEGFA mRNA] Mifepristone results in decreased expression of VEGFA protein Mifepristone affects the expression of VEGFA mRNA Mifepristone results in decreased expression of VEGFA mRNA
Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of VIM mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of VIM protein]
browse the term
